Medical Innovation Exchange

Time runs out for Kronos' phase 3 AML drug as biotech blames enrolment struggles for ending trial

https://www.fiercebiotech.com/biotech/time-runs-out-kronos-phase-3-aml-drug-biotech-blames-enrolment-struggles-ending-trial

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!